Tag: biotechnology
-
T-Cell Therapy Trial Begins for Autoimmune Diseases
A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders.
-
Genetic Techniques Speed Brain, Muscle Cell Production
A new technology targets the expression of genes in stem cells to produce specific brain and muscle cells on demand and in a few days, a fraction of the time now required.
-
Regeneron to Sequence 500K UK Biobank Genomes
A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery.
-
Trial to Test Gene Therapy for Inherited Eye Disease
A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease.
-
Organ Transplant Start-Up Gains $38M in Early Funds
A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round.
-
Allergan to Option Gene Editing for Eye Diseases
International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard.
-
Report: More Biotech Regulations Needed, and Soon
A new report from the National Academies calls for a more robust and responsive regulatory system to handle an anticipated flood of biotechnology products.
-
Precision Medicine, “My Hope for the Future”
A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure.
-
Process Converts Food Waste to Auto Tire Materials
Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques.
-
Trial Underway to Test Cancer Immunotherapy Aid
A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system.